Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Shenyankangfu Tablets for Chronic Kidney Disease
NCT02885857Phase 4Unknown
- Start
- Jun 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Shenyan Kangfu Tablet in primary glomerulonephritis, diabetic nephropathy (DN). Status: unknown.
02
Drugs
Shenyan Kangfu Tablet
03
Conditions
primary glomerulonephritisdiabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT02885857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02885857.